1. Home
  2. Analysis
  3. Robaxin
  4. Hepatic-pain

Robaxin and Hepatic pain - a phase IV clinical study of FDA data

Summary:

Hepatic pain is reported as a side effect among people who take Robaxin (methocarbamol), especially for people who are female, 40-49 old, also take Celebrex, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Hepatic pain when taking Robaxin. It is created by eHealthMe based on reports of 8,252 people who have side effects when taking Robaxin from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Hepatic pain?

Hepatic pain (pain in liver) is found to be associated with 503 drugs and 580 conditions by eHealthMe. Check the latest studies of Hepatic pain.

On Jul, 11, 2026

8,252 people reported to have side effects when taking Robaxin.
Among them, 31 people (0.38%) have Hepatic pain.

Could Robaxin cause Hepatic pain?

Among these 31 people:

What is the gender of people who have Hepatic pain when taking Robaxin? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Hepatic pain when taking Robaxin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 95 %
  • 50-59: 0.0 %
  • 60+: 5 %

What are other drugs people take besides Robaxin? *

  1. Vyvanse: 29 people, 93.55%
  2. Celebrex: 29 people, 93.55%
  3. Erelzi: 28 people, 90.32%
  4. Diclofenac: 26 people, 83.87%
  5. Naproxen: 24 people, 77.42%
  6. Diclofenac Sodium: 17 people, 54.84%
  7. Esomeprazole Magnesium: 16 people, 51.61%
  8. Vimovo: 13 people, 41.94%
  9. Voltaren: 10 people, 32.26%
  10. Diclofenac Potassium: 2 people, 6.45%

What are other side effects people have besides Hepatic pain? *

  1. Abdominal Pain Upper: 30 people, 96.77%
  2. Nausea (feeling of having an urge to vomit): 30 people, 96.77%
  3. Weakness: 29 people, 93.55%
  4. Ear Pain: 29 people, 93.55%
  5. Hepatitis Viral: 29 people, 93.55%
  6. General Physical Health Deterioration (weak health status): 29 people, 93.55%
  7. Gastric Ulcer (stomach ulcer): 29 people, 93.55%
  8. Feeling Abnormal: 29 people, 93.55%
  9. Fatigue (feeling of tiredness): 29 people, 93.55%
  10. Eye Irritation: 29 people, 93.55%

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 28 people, 90.32%
  2. Ankylosing Spondylitis (type of arthritis affecting the spine): 28 people, 90.32%
  3. Headache (pain in head): 1 person, 3.23%
  4. Giant Cell Tumor Of Tendon Sheath: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Hepatic pain?

- Check whether Hepatic pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robaxin:

Hepatic pain treatments and more:

How severe was Hepatic pain and when was it recovered:

Expand to all the drugs that have ingredients of methocarbamol:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic pain:

Browse all the conditions that are associated with Hepatic pain:

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.